A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : p38 MAPK / p38 MAP kinase

[Related PubMed/MEDLINE]
Total Number of Papers: 47
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   p38 MAPK  (>> Co-occurring Abbreviation)
Long Form:   p38 MAP kinase
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Role of Ca⁺ in Inhibiting Ischemia-Induced Apoptosis of Parathyroid Gland Cells in New Zealand White Rabbits. CG, CSG, ELISA, PTH, sham, TUNEL
2019 Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats. GK, I/R, ROS
2019 Cortistatin exerts antiproliferation and antimigration effects in vascular smooth muscle cells stimulated by Ang II through suppressing ERK1/2, p38 MAPK, JNK and ERK5 signaling pathways. alpha-SMA, Ang II, CCK-8, CST, ERK, JNK, MAPK, OPN, PCNA, VSMCs
2019 DeltaNp63alpha modulates phosphorylation of p38 MAP kinase in regulation of cell cycle progression and cell growth. MKP3, Rb
2018 ALDH2 protects against alcoholic cardiomyopathy through a mechanism involving the p38 MAPK/CREB pathway and local renin-angiotensin system inhibition in cardiomyocytes. ACM, AGT, ALDH2, Ang II, CREB, RAS
2018 Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk. CIPN, HATs, HMGB1, ROS
2017 Involvement of Fra-1 in Retinal Ganglion Cell Apoptosis in Rat Light-Induced Retina Damage Model. GCL, LE, RGC
2017 Recuperating Lung Decoction Attenuates the Oxidative Stress State of Chronic Obstructive Pulmonary Disease by Inhibiting the MAPK/AP-1 Signal Pathway and Regulating gamma-GCS. 4-HNE, ERK, gamma-GCSh, RLD
2015 p38 MAP kinase-dependent phosphorylation of the Gp78 E3 ubiquitin ligase controls ER-mitochondria association and mitochondria motility. mAb
10  2014 A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging. COX-2, hMSC, IFN-gamma, PGE2, TNF-alpha
11  2014 Pituitary adenylate cyclase-activating polypeptide (PACAP) inhibits the slow afterhyperpolarizing current sIAHP in CA1 pyramidal neurons by activating multiple signaling pathways. cAMP, PACAP, PKA, sIAHP
12  2013 Ca⁺/calmodulin-dependent protein kinase II contributes to hypoxic ischemic cell death in neonatal hippocampal slice cultures. CaMKII, HI, OGD
13  2013 Hepatitis B virus X protein up-regulates tumor necrosis factor-alpha expression in cultured mesangial cells via ERKs and NF-kappaB pathways. ERKs, GMCs, HBV, NF-kappaB, TNF-alpha
14  2012 Antihyperglycemic potentials of a threatened plant, Helonias dioica: antioxidative stress responses and the signaling cascade. ALX, BW, CAT, COX2, HD, IFN-gamma, iNOS, LPO, NF, ROS, SOD, TNF-alpha
15  2011 Fine-tuned regulation of the PGC-1alpha gene transcription by different intracellular signaling pathways. IREs
16  2011 iNOS/NO signaling regulates apoptosis induced by glycochenodeoxycholate in hepatocytes. GCDC, iNOS, NO, SNAP, SNP
17  2010 Opposite effects of two thiazolidinediones, ciglitazone and troglitazone, on proteinase-activated receptor-1-triggered prostaglandin E(2) release. COX-2, PAR1, PI3K, PPARgamma
18  2010 Preeclampsia-related increase of interleukin-11 expression in human decidual cells. IL, NF-kB, PKC, TNF
19  2009 Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: evidence for PKC activation and oxidative stress-activated signaling pathways. FFAs, IKK, JNK, SAPK
20  2009 JNK and p38 MAPK are independently involved in tributyltin-mediated cell death in rainbow trout (Oncorhynchus mykiss) RTG-2 cells. ERK, JNK, MAPKs, TBT
21  2009 p38 MAP kinase-dependent regulation of the expression level and subcellular distribution of heterogeneous nuclear ribonucleoprotein A1 and its involvement in cellular senescence in normal human fibroblasts. hnRNP A1
22  2009 Proteinase-activated receptor-2-triggered prostaglandin E(2) release, but not cyclooxygenase-2 upregulation, requires activation of the phosphatidylinositol 3-kinase/Akt / nuclear factor-kappaB pathway in human alveolar epithelial cells. COX-2, CREB, EGF, NF-kappaB, PAR2, PI 3-kinase
23  2008 Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation. EGCG, EGF, siRNA, STAT1
24  2007 Mechanisms for prostaglandin E2 formation caused by proteinase-activated receptor-1 activation in rat gastric mucosal epithelial cells. ADAMs, EGFR-TK, HB-EGF, MMP, PAR1, PAR1-AP, PKC
25  2007 P2X7 receptor mediated phosphorylation of p38MAP kinase in the hippocampus. P2X7R, WT
26  2006 Functional analyses of C13orf19/P38IP in prostate cell lines. PCa
27  2006 Low density lipoproteins inhibit the Na+/H+ antiport in human platelets via activation of p38MAP kinase. HSP27, LDL
28  2006 Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster. DCM, JNK, LV
29  2005 Activation of c-Jun-N-terminal kinase is required for apoptosis triggered by glutathione disulfide in neuroblastoma cells. JNK
30  2005 MK2-/- gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia reperfusion injury. MAP, MK2
31  2005 p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor alpha-dependent pathway in response to black tea polyphenols. BAECs, eNOS, ER
32  2005 The molecular basis for coxib inhibition of p38alpha MAP kinase. CoMFA, MAP
33  2005 Thrombin activates the p21-activated kinase in pulmonary artery smooth muscle cells. Role in tissue factor expression. PAK, PASMC, PDK1, PKB, TF
34  2004 A role for p38 MAP kinase in platelet activation by von Willebrand factor. vWF
35  2004 Correlation of MAP kinases with COX-2 induction differs between MKN45 and HT29 cells. COX, ERK, MAP
36  2004 NF-kappa B involved in transcription enhancement of TGF-beta 1 induced by Ox-LDL in rat mesangial cells. ERK, NF-kappaB, oxLDL, PKA, PKC, TGF-beta1
37  2004 Propranolol prevents enhanced stress signaling in Gs alpha cardiomyopathy: potential mechanism for beta-blockade in heart failure. beta-AR, JNK
38  2004 Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain. TbetaR-I
39  2003 p38MAPK induces cell surface alpha4 integrin downregulation to facilitate erbB-2-mediated invasion. HME
40  2001 Hypoxia induces apoptosis by caspase activation accompanying cytochrome C release from mitochondria in MC3T3E1 osteoblasts. p38 MAPK is related in hypoxia-induced apoptosis. ---
41  2000 A selective inhibitor of p38 MAP kinase, SB202190, induced apoptotic cell death of a lipopolysaccharide-treated macrophage-like cell line, J774.1. LPS, TdT
42  2000 Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Ang II, AP-1, ERK, JNK, MAP, ROS, VSMC
43  2000 IL-4 regulation of IL-6 production involves Rac/Cdc42- and p38 MAPK-dependent pathways in keratinocytes. IL, JNK, PAK
44  2000 Induction of signal transduction pathways in rat gastric epithelial cells stimulated with interleukin-1beta. ERKs, IL-1beta, JNKs, MAP, NF
45  2000 MAP Kinase Expression in Eosinophils. ERK, JNK, MAPK, MEK
46  1999 Early platelet activation by low density lipoprotein via p38MAP kinase. LDL, LRP
47  1999 Possible involvement of p38 MAP kinase in HSP70 expression induced by hypoxia in rat primary astrocytes. ---